The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of hyperthermic intraperitoneal chemotherapy on genomic heterogeneity of peritoneal metastases in stage IV gastroesophageal adenocarcinoma.
 
Divya Sood
Stock and Other Ownership Interests - Abbott Laboratories; Boston Scientific; Jazz Pharmaceuticals; Medtronic; Thermo Fisher Scientific; United Health Group
 
Marie L. Fefferman
No Relationships to Disclose
 
Natalie Marie Reizine
No Relationships to Disclose
 
Ryan B. Morgan
No Relationships to Disclose
 
Cecilia T. Ong
No Relationships to Disclose
 
Ankit Dhiman
No Relationships to Disclose
 
Kiran Turaga
No Relationships to Disclose
 
Daniel V.T. Catenacci
Honoraria - Amgen; Archer; Astellas Pharma; Bristol-Myers Squibb; Daiichi Sankyo/UCB Japan; Five Prime Therapeutics; Foundation Medicine; Genentech/Roche; Gritstone Bio; Guardant Health; Lilly; Merck; Natera; Novartis; Pieris Pharmaceuticals; QED Therapeutics; Seagen; Taiho Pharmaceutical; Tempus; Zymeworks
Consulting or Advisory Role - Amgen; Astellas Pharma; Bristol-Myers Squibb; Daiichi Sankyo/UCB Japan; Genentech/Roche; Guardant Health; Lilly; Merck; Seagen; Taiho Pharmaceutical; Zymeworks
Speakers' Bureau - Daiichi Sankyo/Astra Zeneca; Genentech; Guardant Health; Lilly; Merck; Tempus
 
Oliver Eng
Stock and Other Ownership Interests - Aileron Therapeutics; Alpine Immune Sciences; Iovance Biotherapeutics; Zymeworks